Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BETIMOL 0.5% EYE DROPS

timolol
$31.1223per ML

Strength

5.12 mg/mL

Manufacturer

Thea Pharma Inc.

NDC

82584000205

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

2/18/2026

Active Ingredients

TIMOLOL

Approval Type

New Drug (NDA)

FDA Application

NDA020439

On Market Since

11/15/2022

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.6%

3Y

N/A

5Y

N/A

All

-0.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TOPROL XL 50 MG TABLET
Brand
70842011102•Melinta Therapeutics, LLC
$1.3193
per EA
TOPROL XL 25 MG TABLET
Brand
70842011002•Melinta Therapeutics, LLC
$1.3196
per EA
KAPSPARGO SPRINKLE 50 MG CAP
Brand
10631000930•Sun Pharmaceutical Industries Inc.
$1.8920
per EA
KAPSPARGO SPRINKLE 25 MG CAP
Brand
10631000830•Sun Pharmaceutical Industries Inc.
$1.8942
per EA
TOPROL XL 100 MG TABLET
Brand
70842011202•Melinta Therapeutics, LLC
$1.9794
per EA
KAPSPARGO SPRINKLE 100 MG CAP
Brand
10631001030•Sun Pharmaceutical Industries Inc.
$2.2910
per EA
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053025•Azurity Pharmaceuticals Inc.
$2.3056
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053048•Azurity Pharmaceuticals Inc.
$2.3353
per ML
LOPRESSOR 50 MG TABLET
Brand
30698045801•Validus Pharmaceuticals LLC
$2.4163
per EA
TOPROL XL 200 MG TABLET
Brand
70842011302•Melinta Therapeutics, LLC
$3.1607
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy